Send to

Choose Destination
J Pediatr Endocrinol Metab. 2004 Feb;17(2):223-6.

Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.

Author information

Division of Endocrinology, Department of Pediatrics, The Hospital for Sick Children and University of Toronto, Canada.


Data were reviewed from 73 consecutive medical charts of children and adolescents with type 1 diabetes mellitus using insulin pumps for more than 6 months at The Hospital for Sick Children, Toronto, Canada. Statistically significant differences in HbA1c (-0.8%), body mass index (+1.45 kg/m2) and total daily dose of insulin (-0.23 U/kg/day) were found between the start of pump use and evaluation 6-30 months later. There was a close correlation between the HbA1c before and after 6-30 months of pump therapy.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center